The weekly litigation news digest is live. Subscribe now

Crystalline Ingenol Mebutate - EP2558435

The patent EP2558435 was granted to LEO Pharma on Jun 7, 2017. The application was originally filed on Apr 18, 2011 under application number EP11731076A. The patent is currently recorded with a legal status of "Revoked".

EP2558435

LEO PHARMA
Application Number
EP11731076A
Filing Date
Apr 18, 2011
Status
Revoked
Jun 14, 2019
Publication Date
Jun 7, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMar 7, 2018FRKELLYADMISSIBLE
TEVA PHARMACEUTICALSMar 7, 2018D YOUNGADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP1015413
DESCRIPTIONWO2007053912
DESCRIPTIONWO2007059584
DESCRIPTIONWO2007068963
DESCRIPTIONWO2008131491
INTERNATIONAL-SEARCH-REPORTWO2007053912
INTERNATIONAL-SEARCH-REPORTWO2007059584
INTERNATIONAL-SEARCH-REPORTWO2008131491
OPPOSITIONWO2007053912
OPPOSITIONWO2007059584
OPPOSITIONWO2008131491

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents